A detailed history of Dupont Capital Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Dupont Capital Management Corp holds 62,092 shares of ABBV stock, worth $11.8 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
62,092
Previous 62,092 -0.0%
Holding current value
$11.8 Million
Previous $10.7 Million 15.13%
% of portfolio
1.04%
Previous 0.94%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $9.61 Million - $11.2 Million
62,092 New
62,092 $10.7 Million
Q2 2023

Jul 25, 2023

SELL
$132.51 - $164.9 $232,687 - $289,564
-1,756 Reduced 15.82%
9,346 $1.26 Million
Q1 2023

Apr 28, 2023

SELL
$144.61 - $166.54 $588,851 - $678,150
-4,072 Reduced 26.84%
11,102 $1.77 Million
Q4 2022

Jan 26, 2023

SELL
$138.31 - $165.87 $1.64 Million - $1.96 Million
-11,840 Reduced 43.83%
15,174 $0
Q3 2022

Oct 31, 2022

SELL
$134.21 - $153.93 $3.02 Million - $3.46 Million
-22,481 Reduced 45.42%
27,014 $3.63 Million
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $1.66 Million - $2.11 Million
12,037 Added 32.13%
49,495 $7.58 Million
Q1 2022

Apr 27, 2022

BUY
$131.98 - $163.75 $1.44 Million - $1.79 Million
10,916 Added 41.13%
37,458 $6.07 Million
Q4 2021

Jan 31, 2022

SELL
$107.43 - $135.93 $1.79 Million - $2.27 Million
-16,692 Reduced 38.61%
26,542 $3.59 Million
Q3 2021

Nov 03, 2021

SELL
$106.4 - $120.78 $1.25 Million - $1.42 Million
-11,722 Reduced 21.33%
43,234 $4.66 Million
Q2 2021

Jul 30, 2021

SELL
$105.21 - $117.21 $169,703 - $189,059
-1,613 Reduced 2.85%
54,956 $6.19 Million
Q1 2021

Apr 29, 2021

SELL
$102.3 - $112.62 $745,664 - $820,887
-7,289 Reduced 11.41%
56,569 $6.12 Million
Q4 2020

Jan 28, 2021

SELL
$80.49 - $108.67 $245,333 - $331,226
-3,048 Reduced 4.56%
63,858 $6.84 Million
Q3 2020

Oct 29, 2020

SELL
$85.91 - $100.83 $483,157 - $567,067
-5,624 Reduced 7.75%
66,906 $5.86 Million
Q2 2020

Jul 24, 2020

BUY
$73.37 - $98.18 $1.13 Million - $1.52 Million
15,434 Added 27.03%
72,530 $7.12 Million
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $517,096 - $783,982
8,017 Added 16.33%
57,096 $4.35 Million
Q4 2019

Jan 27, 2020

SELL
$72.13 - $90.25 $133,368 - $166,872
-1,849 Reduced 3.63%
49,079 $4.35 Million
Q3 2019

Oct 28, 2019

BUY
$62.98 - $75.72 $231,829 - $278,725
3,681 Added 7.79%
50,928 $3.86 Million
Q2 2019

Jul 30, 2019

SELL
$65.7 - $83.98 $387,630 - $495,482
-5,900 Reduced 11.1%
47,247 $3.44 Million
Q1 2019

Apr 30, 2019

SELL
$77.14 - $90.79 $2.79 Million - $3.28 Million
-36,166 Reduced 40.49%
53,147 $4.28 Million
Q4 2018

Feb 01, 2019

SELL
$77.85 - $96.01 $1.59 Million - $1.96 Million
-20,452 Reduced 18.63%
89,313 $8.23 Million
Q3 2018

Nov 05, 2018

SELL
$88.91 - $98.84 $887,499 - $986,620
-9,982 Reduced 8.34%
109,765 $10.4 Million
Q2 2018

Jul 30, 2018

SELL
$89.78 - $106.23 $1.48 Million - $1.75 Million
-16,490 Reduced 12.1%
119,747 $11.1 Million
Q1 2018

May 02, 2018

BUY
$92.01 - $123.21 $4.12 Million - $5.52 Million
44,828 Added 49.04%
136,237 $12.9 Million
Q4 2017

Jan 31, 2018

BUY
$89.56 - $98.21 $59,199 - $64,916
661 Added 0.73%
91,409 $8.84 Million
Q3 2017

Oct 31, 2017

BUY
$69.85 - $89.22 $6.34 Million - $8.1 Million
90,748
90,748 $8.06 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.